Xiaoping Luo

16.0k total citations · 1 hit paper
223 papers, 7.2k citations indexed

About

Xiaoping Luo is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Xiaoping Luo has authored 223 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 51 papers in Epidemiology and 47 papers in Genetics. Recurrent topics in Xiaoping Luo's work include Hepatitis B Virus Studies (28 papers), Growth Hormone and Insulin-like Growth Factors (24 papers) and Birth, Development, and Health (19 papers). Xiaoping Luo is often cited by papers focused on Hepatitis B Virus Studies (28 papers), Growth Hormone and Insulin-like Growth Factors (24 papers) and Birth, Development, and Health (19 papers). Xiaoping Luo collaborates with scholars based in China, Canada and United States. Xiaoping Luo's co-authors include Qin Ning, Meifang Han, Hongwu Wang, Di Wu, Wei Guo, Da Huang, Huilong Chen, Haijing Yu, Jianxin Song and Tao Chen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Xiaoping Luo

206 papers receiving 7.1k citations

Hit Papers

Clinical and immunological features of severe and moderat... 2020 2026 2022 2024 2020 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical and immunological features of severe and moderate coronavirus disease 2019
    2020 3.2k citations Tao Chen, Meifang Han et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Luo China 36 2.9k 1.6k 1.4k 1.1k 860 223 7.2k
Qin Ning China 40 3.3k 1.1× 1.8k 1.2× 1.5k 1.1× 2.3k 2.1× 1.6k 1.8× 209 8.7k
Juan‐Manuel Anaya Colombia 67 1.8k 0.6× 1.2k 0.7× 1.5k 1.1× 1.8k 1.6× 4.0k 4.6× 344 12.6k
Fabrizio De Benedetti Italy 55 1.4k 0.5× 583 0.4× 3.2k 2.3× 834 0.8× 4.0k 4.6× 304 11.7k
Paolo Rossi Italy 44 1.7k 0.6× 284 0.2× 1.5k 1.1× 1.3k 1.2× 2.5k 2.9× 372 8.4k
Tao Guo China 32 2.3k 0.8× 2.0k 1.2× 1.4k 1.0× 473 0.4× 224 0.3× 213 6.2k
Elliott Vichinsky United States 77 1.0k 0.4× 259 0.2× 2.0k 1.4× 1.4k 1.3× 405 0.5× 432 24.2k
David G. Poplack United States 57 1.3k 0.4× 947 0.6× 2.5k 1.8× 1.1k 1.0× 1.1k 1.3× 225 11.4k

Countries citing papers authored by Xiaoping Luo

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Luo more than expected).

Fields of papers citing papers by Xiaoping Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Luo. The network helps show where Xiaoping Luo may publish in the future.

Co-authorship network of co-authors of Xiaoping Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Luo. A scholar is included among the top collaborators of Xiaoping Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Luo. Xiaoping Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoyan, Xun Jiang, Ying Wang, et al.. (2025). Gastrointestinal complications of hepatic glycogen storage disease: a national survey questionnaire study in China. Orphanet Journal of Rare Diseases. 20(1). 41–41.
2.
Guo, Jixiang, et al.. (2025). Evidence Summary of Early Enteral Nutrition Support for Adult Patients with Extracorporeal Membrane Oxygenation (ECMO). Journal of Multidisciplinary Healthcare. Volume 18. 1557–1569. 1 indexed citations
3.
Liu, Yuan, Xiaoping Luo, Yifei Wang, et al.. (2025). CUDC-907 exerts an inhibitory effect on non-small cell lung cancer associated with induction of mitotic catastrophe and downregulation of YAP/TAZ signaling. Chemico-Biological Interactions. 421. 111735–111735. 1 indexed citations
4.
Zhang, Jian, Zhaoguo Zhang, Xiaoping Luo, et al.. (2024). Coupling between phase transition and spallation in hierarchically structured high-strength martensitic steels under shock loading. Engineering Fracture Mechanics. 309. 110431–110431. 5 indexed citations
5.
Li, Heli, Xinyuan Wang, J. Jean Cui, et al.. (2024). IL-6 Enhances the Activation of PI3K-AKT/mTOR-GSK-3β by Upregulating GRPR in Hippocampal Neurons of Autistic Mice. Journal of Neuroimmune Pharmacology. 19(1). 12–12. 16 indexed citations
6.
Zhang, Meihui, et al.. (2024). Epigenetic modification of Igf2/H19 imprinting control region regulates PGC-1α/PI3K/AKT2 pathway in a rat model of intrauterine growth restriction. Chinese Medical Journal. 138(19). 2472–2480. 1 indexed citations
7.
Wei, Haiyan, Xu Xu, Chunxiu Gong, et al.. (2024). A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty. Advances in Therapy. 41(12). 4537–4556. 1 indexed citations
8.
9.
Chen, Liqing, Xiaoping Luo, Hongling Wang, Tian Yu, & Yan Liu. (2024). Identifying inversions with breakpoints in the Dystrophin gene through long-read sequencing: report of two cases. BMC Medical Genomics. 17(1). 227–227. 1 indexed citations
10.
Xu, Bin, Junyan Li, Xiaoping Luo, et al.. (2024). A one health study on phylogenetics and risk of pathogenic intestinal parasites at a ranch in Inner Mongolia. One Health. 19. 100912–100912. 2 indexed citations
11.
Wan, Xiaoyang, Zhe Shen, Zhongwei Zhang, et al.. (2023). Fibrinogen-like protein 2 regulates macrophage glycolytic reprogramming by directly targeting PKM2 and exacerbates alcoholic liver injury. International Immunopharmacology. 124(Pt B). 110957–110957. 6 indexed citations
12.
Luo, Xiaoping, Cai Zhang, Yu Yang, et al.. (2023). Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study. Advances in Therapy. 40(10). 4574–4588. 2 indexed citations
13.
Fang, Cong, Weiming Yan, Zhiyong Dou, et al.. (2023). Long‐term SARS‐CoV‐2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, China. Journal of Medical Virology. 95(8). e29036–e29036. 4 indexed citations
14.
15.
Hou, Ling, et al.. (2021). History of pediatric type 1 diabetes in China. Pediatric Diabetes. 23(5). 551–555. 2 indexed citations
16.
Zhang, Cai, et al.. (2021). Analysis of the Screening Results for Congenital Adrenal Hyperplasia Involving 7.85 Million Newborns in China: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 12. 624507–624507. 11 indexed citations
17.
Hu, Xiaolin, Ying Wei, Hui Chen, et al.. (2020). Managing Preterm Infants Born to COVID-19 Mothers: Evidence from a Retrospective Cohort Study in Wuhan, China. Neonatology. 117(5). 592–598. 10 indexed citations
18.
Li, Yong, Meifang Han, Weina Li, et al.. (2014). SOCS3 expression correlates with severity of inflammation in mouse hepatitis virus strain 3-induced acute liver failure and HBV-ACLF. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(3). 348–353. 11 indexed citations
19.
Peng, Yi, Zhaohui Yang, Hua Zhang, et al.. (2010). Genetic Variations in Tibetan Populations and High-Altitude Adaptation at the Himalayas. Molecular Biology and Evolution. 28(2). 1075–1081. 300 indexed citations
20.
Jankov, Robert P., Xiaoping Luo, Rosetta Belcastro, et al.. (2003). Fibroblast Growth Factor Receptor-1 and Neonatal Compensatory Lung Growth after Exposure to 95% Oxygen. American Journal of Respiratory and Critical Care Medicine. 167(11). 1554–1561. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qin Ning Breakdown of academic impact, for papers by Juan‐Manuel Anaya Breakdown of academic impact, for papers by Fabrizio De Benedetti Breakdown of academic impact, for papers by Paolo Rossi Breakdown of academic impact, for papers by Tao Guo Breakdown of academic impact, for papers by Elliott Vichinsky Breakdown of academic impact, for papers by David G. Poplack
Rankless by CCL
2026